Loading...
Domestic
Equity
Passive

RISE Healthcare (253280)

Update : 2026.08.07

NAV

12,960KRW

+155.88상승 (1.22%)

Market Price per share (KRW)

12,960KRW

+160상승 (1.25%)

※ t-1 last price

trading volume

2,741shares

AUM

KRW 7.1billion

RISE Healthcare (253280)

KEY POINT

Invest in domestic healthcare companies (medical equipment and services, bio, pharmaceutical)

KEY POINT

Invest in selected healthcare companies based on financial conditions among the top 500 companies by market capitalization of the KOSPI and KOSDAQ markets

Basic information

Download trading information

Update : 2026.08.07
ETF name(Code), Benchmark Index, Inception date, creation unit, Net Asset (KRW 0.1 billion), Trustee, Rule of Dividend payment, Market Price per share (KRW), iNAV per share (KRW), trading volume (share), Total Expense ratio table
ETF Name (code) Benchmark Index Inception date Creation Unit AUM (KRW)
KB RISE HealthCare ETF
(253280)
FnGuide HealthCare Index 2016.09.23 50,000 7,127,958,237
Trustee Market Price per share (KRW) NAV Trading Volume (shares)
하나은행 12,960
※ t-1 last price
12,959 2,741
authorized participant, Liquidity provider table
Total Expense Ratio Distribution Frequency
Year 0.05% (Designated participating company : 0.001%, Collective investment : 0.029%, trust : 0.01%, General affairs : 0.01%) Last business day of January, April, July and October, and end of accounting period (occasional payment)
Authorized Participants Liquidity Providers
KB Securities, Meritz Securities, NH Investment & Securities, Kiwoom Securities, Samsung Securities KB Securities, Meritz Securities, NH Investment & Securities, Kiwoom Securities, Samsung Securities
ETF name(Code), Benchmark Index, Inception date, creation unit, AUM(0.1 billion) (KRW), Trustee, Rule of Dividend payment, Market Price per share (KRW), iNAV per share (KRW), trading volume (share), Total Expense ratio table
ETF Name(Code) Benchmark Index
KB RISE HealthCare ETF

(253280)
FnGuide HealthCare Index
Inception date Creation Unit
2016.09.23 50,000
AUM(0.1 billion) (KRW) Trustee
7,127,958,237 하나은행
Market Price per share (KRW) iNAV per share (KRW)
12,960
※ t-1 last price
12,959
Trading Volume (shares)
2,741
authorized participant, Liquidity provider table
Total Expense Ratio
Year 0.05% (Designated participating company : 0.001%, Collective investment : 0.029%, trust : 0.01%, General affairs : 0.01%)
Distribution Frequency
Last business day of January, April, July and October, and end of accounting period (occasional payment)
Authorized Participants
KB Securities, Meritz Securities, NH Investment & Securities, Kiwoom Securities, Samsung Securities
Liquidity Providers
KB Securities, Meritz Securities, NH Investment & Securities, Kiwoom Securities, Samsung Securities

Index Introduction

The FnGuide Healthcare Index is a market capitalization weighted index. The index selects stocks that satisfy financial and management soundness criteria out of the universe of stocks come under the medical sector in the MKF 500.

View detailed index information

TOP 10 Holdings

Update : 2026-08-07
Rank , Name, proportion table
Rank Name Weight (%)
1 SAMSUNG BIOLOGICS 11.92
2 Celltrion 11.88
3 Alteogen 10.77
4 Yuhan 5.55
5 HLB 5.53
6 ABL Bio 4.54
7 SKBP 4.39
8 LCB 3.87
9 SAMSUNG EPIS HOLDINGS 3.41
10 PharmaResearch 3.37

proportion by sectors

*The proportion of investment stocks

Update : 2026.08.07
Rank , Name, proportion table
Rank Name Weight (%)
1 Healthcare 100.00

Dividend payment data

· Payable date of dividend payment 3 years.
Rule of Dividend payment, Payable date of dividend payment, dividend per share (KRW) table
Rule of Dividend payment Payable date of dividend payment dividend per share (KRW)
2026-04-30 2026-05-06 25
2025-04-30 2025-05-07 20
2023-04-28 2023-05-03 16
2022-04-29 2022-05-03 60

Performance

performance

excel download

Update : 2026-08-07

 (as of Oct : %)

The result of above Net Asset Value performance is the rate of return assuming distribution reinvestment.

classification, 1Month, 3Month, 6Month, 1year, 3year, YTD (Year to date), Since inception, NAV, Benchmark Index, Outperformance table
classification 1Month 3Month 6Month 1year 3year YTD
(Year to date)
Since
inception
NAV -5.37 -20.72 -28.05 -12.79 12.64 -22.92 27.97
Benchmark Index -5.42 -21.10 -28.59 -13.16 12.32 -23.34 28.32
Outperformance 0.04 0.38 0.53 0.37 0.32 0.41 -0.36

daily Performance

excel download

date, market price (KRW), NAV (KRW)
date Market price (KRW) NAV (KRW) Standard Tax Base Price (KRW)
closing price Daily Return(%) closing price Daily Return(%)
2026.08.05 12,960 1.250상승 12,959.92 1.217상승 10,356.46
2026.08.04 12,800 6.889상승 12,804.04 6.444상승 10,356.51
2026.08.03 11,975 0.587상승 12,028.89 1.144상승 10,356.56
2026.07.31 11,905 4.429상승 11,892.89 3.507상승 10,356.71
2026.07.30 11,400 -0.436하락 11,489.83 -0.098하락 10,356.76
2026.07.29 11,450 -3.741하락 11,501.11 -3.690하락 10,356.81
2026.07.28 11,895 -3.135하락 11,941.77 -3.179하락 10,356.86
2026.07.27 12,280 0.986상승 12,333.93 0.981상승 10,356.91
2026.07.24 12,160 0.787상승 12,214.2 0.844상승 10,357.06
2026.07.23 12,065 4.458상승 12,111.93 4.857상승 10,357.11
2026.07.22 11,550 -1.660하락 11,550.83 -1.833하락 10,357.16
2026.07.21 11,745 -1.302하락 11,766.58 -0.894하락 10,357.21
2026.07.20 11,900 -3.291하락 11,872.76 -3.339하락 10,357.26
2026.07.16 12,305 -1.283하락 12,283.1 -0.980하락 10,357.47
2026.07.15 12,465 5.101상승 12,404.7 4.707상승 10,357.52
2026.07.14 11,860 -3.380하락 11,846.99 -3.704하락 10,357.56
2026.07.13 12,275 -4.026하락 12,302.78 -3.672하락 10,357.61
2026.07.10 12,790 0.431상승 12,771.92 0.200상승 10,357.75
2026.07.09 12,735 -1.849하락 12,746.3 -1.760하락 10,357.8
2026.07.08 12,975 -4.630하락 12,974.74 -4.499하락 10,357.85
2026.07.07 13,605 3.029상승 13,586.08 2.309상승 10,357.9

Holdings

Name, Ticker, Number. of shares, Weight(%), market price (KRW)
No. (Number) Name Ticker Number of shares Weight(%) Market price (KRW)
1 SAMSUNG BIOLOGICS KR7207940008 52 11.92 77,532,000
2 Celltrion KR7068270008 406 11.88 77,261,800
3 Alteogen KR7196170005 253 10.77 70,081,000
4 Yuhan KR7000100008 481 5.55 36,123,100
5 HLB KR7028300002 1,030 5.53 35,947,000
6 ABL Bio KR7298380007 368 4.54 29,513,600
7 SKBP KR7326030004 348 4.39 28,536,000
8 LCB KR7141080002 230 3.87 25,185,000
9 SAMSUNG EPIS HOLDINGS KR70126Z0002 57 3.41 22,173,000
10 PharmaResearch KR7214450009 58 3.37 21,924,000
11 HanmiPharm KR7128940004 55 3.21 20,900,000
12 SCD KR7000250001 121 3.1 20,158,600
13 HANALL BIOPHARMA KR7009420001 306 2.5 16,248,600
14 Hugel KR7145020004 46 1.84 11,960,000
15 ST Pharm KR7237690003 113 1.75 11,390,400
16 CLASSYS KR7214150005 232 1.6 10,416,800
17 ORUM KR7475830006 161 1.46 9,499,000
18 L&C BIO KR7290650001 158 1.4 9,132,400
19 SKBS KR7302440003 230 1.22 7,958,000
20 SEEGENE KR7096530001 278 1.2 7,797,900
21 Celltrionph KR7068760008 178 1.15 7,476,000
22 원화예금 KRD010010001 7,200,343 1.11 7,200,343
23 Hanmi Science KR7008930000 176 1.09 7,101,600
24 Lunit KR7328130000 608 1.01 6,542,080
25 GC Biopharma Corp. KR7006280002 48 0.9 5,870,400
26 Pharmicell KR7005690003 485 0.85 5,538,700
27 T&L KR7340570001 79 0.8 5,182,400
28 HK inno.N KR7195940002 123 0.77 4,981,500
29 DAEWOONG PHARM KR7069620003 39 0.75 4,855,500
30 CHA Biotech KR7085660009 520 0.73 4,737,200
31 CHONGKUNDANG KR7185750007 69 0.72 4,657,500
32 DongKook Pharm KR7086450004 205 0.58 3,755,600
33 MedyTox KR7086900008 47 0.55 3,609,600
34 i-SENS KR7099190001 189 0.54 3,515,400
35 JWPHARMA KR7001060003 116 0.43 2,824,600
36 ShinpoongPharm KR7019170000 345 0.43 2,808,300
37 ILDONG PHARM KR7249420001 183 0.42 2,743,170
38 HLBPHARMA KR7047920004 321 0.41 2,689,980
39 DENTIUM KR7145720009 57 0.36 2,317,050
40 CUREXO KR7060280005 253 0.35 2,292,180
41 EuBio KR7206650004 271 0.35 2,276,400
42 WONTECH KR7336570007 374 0.3 1,956,020
43 GC Corp. KR7005250006 188 0.29 1,891,280
44 Binex KR7053030003 250 0.27 1,747,500
45 Huons Global KR7084110006 47 0.18 1,189,100
46 KLS KR7102940004 65 0.16 1,058,200
Investment notice
- The information provided on this website is based on reliable sources, but its accuracy and completeness are not guaranteed.
- Financial investment products are not protected by the Korea Deposit Insurance Corporation in accordance with the Depositor Protection Act, and a loss of investment principal may occur, which belongs to the investor.
- Past performance does not guarantee future profits.
- In the case of a collective investment scheme that invests in foreign securities, asset values may be lost due to risks caused by market, political, and economic conditions in the target country.
- Derivatives may lose all or a significant portion of the investment principal in a short period of time due to high price volatility, and there is a risk that the counterparty may not be able to fulfill the terms of the contract when investing in over-the-counter derivatives.
- Before investing, be sure to read the investment prospectus and contract recommendation document regarding the investment subject, redemption method, and fee.